Business Context and Reporting Period
P3 Health Partners Inc. filed this Form 8-K on May 20, 2026, regarding its listing status on The Nasdaq Stock Market LLC. The report addresses the Company's compliance with Nasdaq Listing Rule 5550(b) following a prior notice of non-compliance issued on November 28, 2025.
Key Financial Metrics
This filing does not contain specific financial statements, revenue, profit, cash flow, or debt figures. The document references the following Nasdaq listing standards as the basis for the compliance determination:
- Stockholders' equity of at least $2.5 million.
- Market value of listed securities of at least $35 million.
- Net income from continuing operations of at least $500,000.
Material Changes
The primary material change is the restoration of the Company's compliance with Nasdaq continued listing requirements. On May 20, 2026, Nasdaq staff determined that the Company now complies with Listing Rule 5550(b)(2) based on information provided in a Form 8-K filed on May 15, 2026. This resolves the delisting risk previously identified in November 2025.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks. The document focuses solely on the administrative resolution of the listing deficiency. No unusual items or contingencies were disclosed in this specific report.
Investor Verification Checklist
- Verify the specific financial metrics disclosed in the Form 8-K filed on May 15, 2026, which served as the basis for the compliance determination.
- Confirm the current trading status of Class A common stock (PIII) and warrants (PIIIW) on Nasdaq.
- Review the November 28, 2025, Form 8-K to understand the initial non-compliance details.